Your satisfaction is our top priority, and we are committed to providing the highest quality service.
To help us continue improving and to ensure that we meet your expectations,
we kindly ask you to take a few moments to complete this survey.
Your feedback is invaluable to us as we strive to enhance your experience and the service we provide.
Thank you for your time and input.
TEST ANNOUNCEMENTS
10/01/2024: Urgent Testing Update for Mycoplasma pneumoniae.
Due to the recent surge in M. pneumoniae concerns, Dayton Children’s Hospital Laboratory Services has an important update regarding testing availability with education to support this test. The following options are currently available:
DCH in house testing
M. pneumoniae is only available within the RIDPC panel |
DCH send out testing
Available as an independent test by our reference lab partner |
| TAT <24 hours |
TAT 2-5 days |
| Order: RIDPC (panel) |
Order: MPPCR (independent test) |
| FDA approved |
Lab developed test (PCR) |
| CPT: 0202U |
CPT: 87581 |
| DCH Charge: $613.27 |
DCH Charge: $268.14 |
Due to low test volumes and required FDA approval, DCH does not have an individual laboratory developed test for Mycoplasma pneumonia. The following tests are included in the RIDPC panel:
- Adenovirus
- Chlamydia pneumoniae
- Coronavirus (HKU1, OC43, NL63)
- Influenza A (H1-2009, H1 seasonal, H3)
- Influenza B
- Human Metapneumovirus (hMPV)
- Mycoplasma pneumoniae
- Parainfluenza (1,2,3,4)
- Rhinovirus/Enterovirus
- Respiratory syncytial virus, or RSV
- SARS-CoV2
|
|
09/30/2024: All Positive C. difficile PCR assays will be confirmed by Cytotoxin assay.
At the request of the Laboratory Stewardship Committee, Infectious Disease Department, and Gastroenterology Department, the Molecular Infectious Disease Lab will confirm all positive C. difficile PCR results with a Cytotoxin Assay. This change will take advantage of the Sensitivity of PCR combined with the Specificity of a Toxin Assay. Negative PCRs will be reported immediately, and Positive PCRs will be reported with the Cytotoxin assay result within 24-48 hours. Tests will be resulted as:
| Situation |
Results |
| PCR Negative |
Negative for C. difficile by PCR |
PCR Positive &
Cytotoxin Positive |
C. DIFFICILE PCR POSITIVE, CYTOTOXIN POSITIVE Patient most likely has disease if signs/symptoms of C. difficile infection are present |
PCR Positive &
Cytotoxin Negative |
C. DIFFICILE PCR POSITIVE, Cytotoxin Negative Patient most likely colonized |
| PCR Positive & Cytotoxin is pending, a preliminary report will be generated: |
Confirmation by Cytotoxin assay to follow in
24-48 hrs |
Please contact the Molecular Infectious Disease Laboratory (937-641-3907) with any questions. |
09/27/2024: A result for EBV Early AB (EA) will no longer be reported with results of Epstein Barr Antibody Evaluation testing.
Testing for EA is not required to assess for primary EBV-associated infection, and EA titers are falsely positive in 10-20% of cases. EA will stay positive in 20% of healthy people with a remote history (i.e. > 6 months prior to testing) of EBV infection.
For severely immunocompromised individuals with a documented history of EBV infection confirmed by prior EBV Antibody Evaluation testing results, a positive EA antibody titer result could potentially be used to help assess for EBV infection reactivation. For such cases, please contact the DCH Virology laboratory for additional information. |
Tests not performed at Dayton Children's Hospital are sent to a referral laboratory.
Outside links to referral laboratory order forms should not be utilized; please order tests directly through DCH, and we will facilitate the process.
|
Genetic testing requires a referral to Genetics.
|
Laboratory Stewardship aims to ensure that proper tests are ordered, that the retrieval and interpretation of laboratory results is accurate, and that financial responsibility is maintained.
Contact the Laboratory Stewardship Coordinator:
CLIA Certificates for all testing center locations are available upon request.
Your satisfaction is our top priority, and we are committed to providing the highest quality service.
To help us continue improving and to ensure that we meet your expectations,
we kindly ask you to take a few moments to complete this survey.
Your feedback is invaluable to us as we strive to enhance your experience and the service we provide.
Thank you for your time and input.
TEST ANNOUNCEMENTS
10/01/2024: Urgent Testing Update for Mycoplasma pneumoniae.
Due to the recent surge in M. pneumoniae concerns, Dayton Children’s Hospital Laboratory Services has an important update regarding testing availability with education to support this test. The following options are currently available:
DCH in house testing
M. pneumoniae is only available within the RIDPC panel |
DCH send out testing
Available as an independent test by our reference lab partner |
| TAT <24 hours |
TAT 2-5 days |
| Order: RIDPC (panel) |
Order: MPPCR (independent test) |
| FDA approved |
Lab developed test (PCR) |
| CPT: 0202U |
CPT: 87581 |
| DCH Charge: $613.27 |
DCH Charge: $268.14 |
Due to low test volumes and required FDA approval, DCH does not have an individual laboratory developed test for Mycoplasma pneumonia. The following tests are included in the RIDPC panel:
- Adenovirus
- Chlamydia pneumoniae
- Coronavirus (HKU1, OC43, NL63)
- Influenza A (H1-2009, H1 seasonal, H3)
- Influenza B
- Human Metapneumovirus (hMPV)
- Mycoplasma pneumoniae
- Parainfluenza (1,2,3,4)
- Rhinovirus/Enterovirus
- Respiratory syncytial virus, or RSV
- SARS-CoV2
|
|
09/30/2024: All Positive C. difficile PCR assays will be confirmed by Cytotoxin assay.
At the request of the Laboratory Stewardship Committee, Infectious Disease Department, and Gastroenterology Department, the Molecular Infectious Disease Lab will confirm all positive C. difficile PCR results with a Cytotoxin Assay. This change will take advantage of the Sensitivity of PCR combined with the Specificity of a Toxin Assay. Negative PCRs will be reported immediately, and Positive PCRs will be reported with the Cytotoxin assay result within 24-48 hours. Tests will be resulted as:
| Situation |
Results |
| PCR Negative |
Negative for C. difficile by PCR |
PCR Positive &
Cytotoxin Positive |
C. DIFFICILE PCR POSITIVE, CYTOTOXIN POSITIVE Patient most likely has disease if signs/symptoms of C. difficile infection are present |
PCR Positive &
Cytotoxin Negative |
C. DIFFICILE PCR POSITIVE, Cytotoxin Negative Patient most likely colonized |
| PCR Positive & Cytotoxin is pending, a preliminary report will be generated: |
Confirmation by Cytotoxin assay to follow in
24-48 hrs |
Please contact the Molecular Infectious Disease Laboratory (937-641-3907) with any questions. |
09/27/2024: A result for EBV Early AB (EA) will no longer be reported with results of Epstein Barr Antibody Evaluation testing.
Testing for EA is not required to assess for primary EBV-associated infection, and EA titers are falsely positive in 10-20% of cases. EA will stay positive in 20% of healthy people with a remote history (i.e. > 6 months prior to testing) of EBV infection.
For severely immunocompromised individuals with a documented history of EBV infection confirmed by prior EBV Antibody Evaluation testing results, a positive EA antibody titer result could potentially be used to help assess for EBV infection reactivation. For such cases, please contact the DCH Virology laboratory for additional information. |
Tests not performed at Dayton Children's Hospital are sent to a referral laboratory.
Outside links to referral laboratory order forms should not be utilized; please order tests directly through DCH, and we will facilitate the process.
|
Genetic testing requires a referral to Genetics.
|
Laboratory Stewardship aims to ensure that proper tests are ordered, that the retrieval and interpretation of laboratory results is accurate, and that financial responsibility is maintained.
Contact the Laboratory Stewardship Coordinator:
CLIA Certificates for all testing center locations are available upon request.
.png)
